• 제목/요약/키워드: Squamous carcinoma cell

검색결과 1,607건 처리시간 0.045초

개에서 피부 편평상피세포암의 발생과 치료 예 (Squamous cell carcinoma of the skin in an Australian shepherd dog)

  • 권오덕
    • 한국동물위생학회지
    • /
    • 제24권1호
    • /
    • pp.101-107
    • /
    • 2001
  • Squamous cell carcinoma of the skin was diagnosed in an 11-year-old, Australian shepherd dog with a hard mass on the right rump area. On histopathological examination of the tumor showed laminated keratin "pearls" surrounded by proliferated squamous cells, and mitotic figures. The dog was treated by surgical excision and chemotherapy with vinblastine sulfate, cyclophosphamide and prednisolone for 4 weeks. The tumor was effectively treated with a combination of surgery and chemotherapy.motherapy.

  • PDF

Antitumor effects of valdecoxib on hypopharyngeal squamous carcinoma cells

  • Trang, Nguyen Thi Kieu;Yoo, Hoon
    • The Korean Journal of Physiology and Pharmacology
    • /
    • 제26권6호
    • /
    • pp.439-446
    • /
    • 2022
  • The antitumoral effects of valdecoxib (Val), an United States Food and Drug Administration-approved anti-inflammatory drug that was withdrawn due to the side effects of increased risk of cardiovascular adverse events, were investigated in hypopharyngeal squamous cell carcinoma cells by performing a cell viability assay, transwell assay, immunofluorescence imaging, and Western blotting. Val markedly inhibited cell viability with an IC50 of 67.3 µM after 48 h of treatment, and also downregulated cell cycle proteins such as Cdks and their regulatory cyclin units. Cell migration and invasion were severely suppressed by inhibiting integrin α4/FAK expression. In addition, Val activated the cell cycle checkpoint CHK2 in response to excessive DNA damage, which led to the activation of caspase-3/9 and induced caspase-dependent apoptosis. Furthermore, the signaling cascades of the PI3K/AKT/mTOR and mitogen-activated protein kinase pathways were significantly inhibited by Val treatment. Taken together, our results indicate that Val can be used for the treatment of hypopharyngeal squamous cell carcinoma.

혈관내피세포성장인자 억제제에 의한 구강편평상피세포암종 세포주의 성장 억제 효과 (ANTI-TUMOR EFFECTS OF VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITOR ON ORAL SQUAMOUS CELL CARCINOMA CELL LINES)

  • 한세진;이재훈
    • Journal of the Korean Association of Oral and Maxillofacial Surgeons
    • /
    • 제35권2호
    • /
    • pp.66-73
    • /
    • 2009
  • Tumor angiogenesis is a process leading to formation of blood vessels within tumors and is crucial for maintaining a supply of oxygen and nutrients to support tumor growth and metastasis. Vascular endothelial growth factor(VEGF) plays a key role in tumor angiogenesis including induction of endothelial cell proliferation, migration, survival and capillary tube formation. VEGF binds to two distinct receptors on endothelial cells. VEGFR-2 is considered to be the dominant signaling receptor for endothelial cell permeability, proliferation, and differentiation. Bevacizumab(Avastin, Genetech, USA) is a monoclonal antibody against vascular endothelial growth factor. It is used in the treatment of cancer, where it inhibits tumor growth by blocking the formation of new blood vessels. The goal of this study is to identify the anti-tumor effect of Bevacizumab(Avastin) for oral squamous cell carcinoma cell lines. Human squamous cell carcinoma cell line(HN4) was used in this study. We examined the sensitivity of HN4 cell line to Bevacizumab(Avastin) by using in vitro proliferation assays. The results were as follows. 1. In the result of MTT assay according to concentration of Bevacizumab(Avastin), antiproliferative effect for oral squamous cell carcinoma cell lines was observed. 2. The growth curve of cell line showed the gradual growth inhibition of oral squamous cell carcinoma cell lines after exposure of Bevacizumab(Avastin). 3. In the apoptotic index, groups inoculated Bevacizumab(Avastin) were higher than control groups. 4. In condition of serum starvation, VEGFR-2 did not show any detectable autophosphorylation, whereas the addition of VEGF activated the receptor. Suppression of phosphorylated VEGFR-2 and phosphorylated MAPK was observed following treatment with Bevacizumab(Avastin) in a dose-dependent manner. 5. In TEM view, dispersed nuclear membrane, scattered many cytoplasmic vacuoles and localized chromosomal margination after Bevacizumab(Avastin) treatment were observed. These findings suggest that Bevacizumab(Avastin) has the potential to inhibit MAPK pathway in proliferation of oral squamous cell carcinoma cell lines via inhibition of VEGF-dependent tumor growth.

두개골과 뇌경질막까지 침윤된 매우 공격적인 임상양상을 보이는 두피의 편평세포암 (Aggressive Squamous Cell Carcinoma of the Scalp with Invasion into the Skull and Dura Mater)

  • 박선희;이종원;서제원;오득영;이중호;안상태
    • 대한두개안면성형외과학회지
    • /
    • 제10권2호
    • /
    • pp.138-141
    • /
    • 2009
  • Purpose: Squamous cell carcinoma of the scalp sometimes exhibits unusually aggressive behavior. We report a case of extradordinarily aggressive squamous cell carcinoma of the scalp with invasion into the skull and dura mater. Method: The patient is a 38-year-old man with two cystic masses on the occipital area. He was diagnosed as squamous cell carcinoma in that region and have undergone surgical resections including cortical osteotomy of the skull, several years ago. On this occasion, 3-dimensional computed tomographic imaging revealed an erosive lesion on the occipital bone and magnetic resonance imaging showed two cystic masses invasion into the skull and dura mater. Results: He has undergone wide resection of the masses and cranioplasty with dural repair. Histopathologic examination indicated squamous cell carcinoma with moderate differentiation of the masses, bone marrow and dura mater. Conclusion: Squamous cell carcinoma on the scalp can readily penetrate the full thickness of the cranium and invade the dura mater, sagittal sinus and brain. We suggest wide resection of the scalp and split thickness skin graft with sentinel lymph node biopsy, following by postoperative radiation therapy.

이하선으로 직접 전이한 피부 편평상피세포암 (A Case of Direct Invasion of the Parotid Gland by Cutaneous Squamous Cell Carcinoma)

  • 이준호;신혜경;최진수;장태정
    • 대한두개안면성형외과학회지
    • /
    • 제14권2호
    • /
    • pp.129-132
    • /
    • 2013
  • Cutaneous squamous cell carcinoma is the second-most common skin cancer and represents 20% of all skin cancers. Cutaneous squamous cell carcinoma often spreads to the parotid gland through lymph nodes, but, direct invasion of an adjacent organ may also occur. We present the case of 78-year-old man with ulcerated mass on the right infra-auricular area. The histopathologic finding was squamous cell carcinoma. There was no evidence of distant metastasis, but the mass was found to invade the superficial lobe of the right parotid gland. The mass was widely excised and superficial parotidectomy was performed while preserving the facial nerve. The defect was covered by primary closure. Postoperative radiotherapy was performed. At 20 months after surgery, our patient had no facial palsy, local recurrence, or metastasis. Cutaneous squamous cell carcinoma involving the parotid gland is an aggressive, rapidly advancing lesion, which if not recognized and treated early will result in high morbidity and mortality. Squamous cell carcinoma of the parotid gland has shown that patients who receive adjuvant radiotherapy have a lower recurrence rate and a higher survival rate than patients treated with surgery alone. The role of elective neck dissection remains controversial.

Screening for MiRNAs Related to Laryngeal Squamous Carcinoma Stem Cell Radiation

  • Huang, Chang-Xin;Zhu, Ying;Duan, Guang-Liang;Yao, Ji-Fen;Li, Zhao-Yang;Li, Da;Wang, Qing-Qing
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권8호
    • /
    • pp.4533-4537
    • /
    • 2013
  • Objective: To use microarray chip technology for screening of stem cell radiation related miRNAs in laryngeal squamous cell carcinoma; study and explore the relationship of miRNAs with radiosensitivity of laryngeal squamous cells. Method: After conventional culture and amplification of the laryngeal squamous carcinoma cell line Hep-2, CD 133+ cells were screened out with combination of isolated culture of stem cell microspheres and FACS for preparation of laryngeal cancer stem cells. After radiation treatment, miRNAs of laryngeal squamous carcinoma stem cells before and after radiation were enriched and purified. After microarray hybridization with mammalian miRNA and scanning of fluorescence signal, the miRNAs of laryngeal squamous carcinoma stem cells before and after radiation was subject to differential screening and clustering analysis. Real-time quantitative RT-PCR was used to verify part of the differentially expressed miRNAs. Results: 70 miRNAs related to laryngeal cancer stem cell radiation with 2-fold difference in expression were screened out, in which 62 were down-regulated and 8 were up-regulated. Fluorescent quantitative RT-PCR results were consistent with miRNAs chip results. Conclusion: Some miRNAs may be involved in self-regulation with laryngeal squamous carcinoma stem cell radiation.

폐의 기저세포양 편평세포암: 두 개의 증례 보고와 전산화단층촬영 영상소견 (Basaloid Squamous Cell Carcinoma of the Lung: Two Case Reports with CT Imaging Findings)

  • 김주희;윤현정;이은주;김은주
    • 대한영상의학회지
    • /
    • 제81권3호
    • /
    • pp.746-752
    • /
    • 2020
  • 폐의 기저세포양 편평세포암은 2015년 WHO 분류체계에서 편평세포암의 한 아형으로 분류되었고 폐암에서는 드물기에 잘 알려지지 않은 유형이다. 저자들은 두 기저세포양 편평세포암 증례를 보고하고 이들의 전산화단층촬영 영상소견을 명시하고자 한다. 85세 그리고 68세의 기저세포양 편평세포암을 가진 환자가 내원하여 수술적 절제를 시행 받았다. 전산화단층 촬영에서 두 병변은 각각 3.1과 2.8 cm 크기로 경계가 좋으며, 둥글면서 소엽상 경계였고 내부는 괴사를 시사하는 저음영이 풍부하였다. 후자는 수술 후 20개월 동안 추적 관찰하였고 전산화단층촬영에서 재발은 없었다. 비록 드문 아형의 폐암이지만 이러한 전산화단층촬영 소견을 공유한다면 기저세포양 편평세포암을 고려해 볼 수 있겠다.

갑상선에 발생한 원발성 편평세포암 1예 (A Case of Primary Squamous Cell Carcinoma of the Thyroid Gland)

  • 설정훈;김홍준;홍재민;노경진;홍현준
    • 대한두경부종양학회지
    • /
    • 제26권2호
    • /
    • pp.240-242
    • /
    • 2010
  • Primary squamous cell carcinoma of the thyroid gland is a very rare event, representing much less than 1% of all malignant tumors of the thyroid gland. The cancer is characterized by rapidly progressive clinical course in spite of its differentiated morphologic features. In most cases, a squamous epithelium is believed to be a result of metaplasia of a follicular epithelium, although in rare exceptions, it can originate from a remnant of the thyroglossal duct or ultimobranchial body. Squamous cell carcinoma of the thyroid gland can occur in a pure form or mixed with adenocarcinoma. Because their clinical behavior is more aggressive than that of other malignant neoplasm of thyroid gland, the tumor should be treated more vigorously at its initial stage. Recently, authors experienced one case of primary squamous cell carcinoma of the thyroid gland. We report our case with a brief review of literature.

Delayed diagnosis of a primary intraosseous squamous cell carcinoma: A case report

  • Abdelkarim, Ahmed Z.;Elzayat, Ahmed M.;Syed, Ali Z.;Lozanoff, Scott
    • Imaging Science in Dentistry
    • /
    • 제49권1호
    • /
    • pp.71-77
    • /
    • 2019
  • Primary intraosseous squamous cell carcinoma is a rare malignant central jaw tumor derived from odontogenic epithelial remnants. Predominantly, it affects mandible, although both jaw bones may be involved. This report describes a 60-year-old man who was initially misdiagnosed with a periapical infection related to the right lower wisdom tooth. After four months, the patient presented to a private dental clinic with a massive swelling at the right side of the mandible. Panoramic radiographs and advanced imaging revealed a lesion with complete erosion of the right ramus, which extended to the orbital floor. A biopsy from the mandibular angle revealed large pleomorphic atypical squamous cells, which is the primary microscopic feature of a poorly differentiated squamous cell carcinoma.